2024<\/p><\/td> | 1<\/p><\/td><\/tr><\/tbody><\/table> Source: data provided by the MHRA.<\/p> \u201cPersistent sexual dysfunction\u201d does not represent a specific medical condition, so this precise term is not a category available for a structured search of the MHRA\u2019s Adverse Drug Reaction database. The structured data field search terms are drawn from the regulatory drugs dictionary, MedDRA, or from terms adopted in clinical coding guidance such as The Diagnostic and Statistical Manual of Mental Disorders Fifth Edition<\/em>, or the International Classification of Diseases 11th Revision<\/em>. A search of the database would therefore rely on manual assessment of individual cases.<\/p>It is important to note that the inclusion of a particular report on the MHRA\u2019s system does not necessarily mean that the adverse reactions reported have been caused by the suspect drug. Additionally, the number of reports received should not be used as a basis for determining the incidence of a reaction, as neither the total number of reactions occurring, nor the number of patients using the drug, is known.<\/p> The product information for trazodone, which includes the patient information leaflet, reflects the data currently available, and does not include sexual dysfunction as a possible side effect but does include priapism, the prolonged erection of the penis. The Summary of Product Characteristics for healthcare professionals states that there have been reports of priapism which have required surgical intervention, or led to permanent sexual dysfunction. Patients developing priapism should stop using trazodone immediately.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/347", "label" : {"_value" : "Biography information for Baroness Merron"}
}
, "answeringMemberPrinted" : {"_value" : "Baroness Merron"}
, "dateOfAnswer" : {"_value" : "2024-08-06", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-08-06T15:04:58.02Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-07-29", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Trazodone: Sexual Dysfunction"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask His Majesty's Government how many prescriptions for trazodone have been issued in each year since 2014; how many 'Yellow Card' reports of sexual dysfunction and persistent sexual dysfunction in respect of trazodone the MHRA has received each year since 2014; and what consideration NHS England has given to adding sexual dysfunction as a side effect on the patient information leaflets for trazodone.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/738", "label" : {"_value" : "Biography information for Lord Alton of Liverpool"}
}
, "tablingMemberPrinted" : [{"_value" : "Lord Alton of Liverpool"}
], "uin" : "HL401"}
, {"_about" : "http://data.parliament.uk/resources/1723956", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1723956/answer", "answerText" : {"_value" : " The government is carefully considering the valuable work done by the Hughes Report and will respond in due course.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/347", "label" : {"_value" : "Biography information for Baroness Merron"}
}
, "answeringMemberPrinted" : {"_value" : "Baroness Merron"}
, "dateOfAnswer" : {"_value" : "2024-08-02", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-08-02T13:59:02.03Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-07-29", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Sodium Valproate and Surgical Mesh Implants: Compensation"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask His Majesty's Government, further to the Written Answer by Baroness Merron on 26 July (HL259), by which date they expect to issue a response to the Hughes Report, and whether they plan to offer compensation as the report recommends.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4909", "label" : {"_value" : "Biography information for Lord Kamall"}
}
, "tablingMemberPrinted" : [{"_value" : "Lord Kamall"}
], "uin" : "HL430"}
, {"_about" : "http://data.parliament.uk/resources/1723969", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1723969/answer", "answerText" : {"_value" : " The Joint Committee on Vaccination and Immunisation considered uptake when developing their advice on a maternal respiratory syncytial virus (RSV) vaccination programme. Uptake for the RSV vaccination programme is expected to be like that of other year-round maternal respiratory immunisation programmes.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/347", "label" : {"_value" : "Biography information for Baroness Merron"}
}
, "answeringMemberPrinted" : {"_value" : "Baroness Merron"}
, "dateOfAnswer" : {"_value" : "2024-08-06", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-08-06T08:24:41.58Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-07-29", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Respiratory Syncytial Virus: Vaccination"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask His Majesty's Government what assessment they have made of the expected coverage rates of maternal respiratory syncytial virus vaccination in the first year of the programme.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4130", "label" : {"_value" : "Biography information for Baroness Ritchie of Downpatrick"}
}
, "tablingMemberPrinted" : [{"_value" : "Baroness Ritchie of Downpatrick"}
], "uin" : "HL443"}
, {"_about" : "http://data.parliament.uk/resources/1723970", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1723970/answer", "answerText" : {"_value" : " The UK Health Security Agency (UKHSA) routinely monitors and reviews the vaccination coverage of all the routine immunisation programmes in England. Flu vaccine uptake for pregnant women for the 2023/24 flu season was 31.2%. Pertussis vaccine uptake for pregnant women for 2024, from January to April, was 59.1%.<\/p> To improve coverage rates for all maternal immunisations, the UKHSA provides public facing information, including information leaflets in multiple languages and accessible formats. The UKHSA also provides training slides and information resources for healthcare professionals.<\/p> Ahead of delivering a new vaccination programme for the respiratory syncytial virus (RSV), the UKHSA hosted two RSV webinars for healthcare professionals: the older person RSV vaccine programme; and the maternal RSV programme. Resources are also available for the RSV programme on the Health Publications Website.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/347", "label" : {"_value" : "Biography information for Baroness Merron"}
}
, "answeringMemberPrinted" : {"_value" : "Baroness Merron"}
, "dateOfAnswer" : {"_value" : "2024-08-05", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-08-05T16:03:21.343Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-07-29", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Influenza and Whooping Cough: Vaccination"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask His Majesty's Government what are the national coverages rates of (1) influenza, and (2) pertussis, vaccination among pregnant women, and what steps they are taking to improve coverage rates for all maternal immunisations, ahead of delivering a new vaccination programme for the respiratory syncytial virus.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4130", "label" : {"_value" : "Biography information for Baroness Ritchie of Downpatrick"}
}
, "tablingMemberPrinted" : [{"_value" : "Baroness Ritchie of Downpatrick"}
], "uin" : "HL444"}
, {"_about" : "http://data.parliament.uk/resources/1723971", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1723971/answer", "answerText" : {"_value" : " The Government is committed to raising the healthiest generation of children in our history. This will include giving children a healthy, happy start to life, and protecting them from the growth of infectious diseases.<\/p> To achieve this, the Department works with NHS England and the UK Health Security Agency to make accurate and up to date information on the benefits of vaccines and their eligibility, available to parents, carers, and patients. We are also learning lessons from the COVID-19 vaccine programme about the power of real-time, specific data to improve uptake, as well as looking at system changes for delivery, to make getting vaccinated easier for all.\u202fThe Department, alongside partners, is also exploring how to enable vaccinations for babies and children as part of health visits.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/347", "label" : {"_value" : "Biography information for Baroness Merron"}
}
, "answeringMemberPrinted" : {"_value" : "Baroness Merron"}
, "dateOfAnswer" : {"_value" : "2024-08-06", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-08-06T08:26:28.183Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-07-29", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Health: Children"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask His Majesty's Government what actions they are taking to deliver Labour\u2019s Child Health Action Plan, and in particular what actions they will take to improve access to childhood immunisation.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4130", "label" : {"_value" : "Biography information for Baroness Ritchie of Downpatrick"}
}
, "tablingMemberPrinted" : [{"_value" : "Baroness Ritchie of Downpatrick"}
], "uin" : "HL445"}
, {"_about" : "http://data.parliament.uk/resources/1723975", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1723975/answer", "answerText" : {"_value" : " A consultation was run in 2023 on the interim delivery plan for myalgic encephalomyelitis, also known as chronic fatigue syndrome (ME/CFS). In the World ME Day Westminster Hall debate in May 2024, the current Parliamentary Under-Secretary of State for Public Health and Prevention pushed for the publication of a response to the consultation. It is now a priority for the Department, and it is our intention to publish a response in the coming months. The consultation responses, along with continued close engagement with stakeholders, will inform the development of the Final Delivery Plan<\/em>, which we aim to publish in the winter of 2024/25.<\/p>No specific assessment has been made of the proportion of the research budget allocated for ME/CFS or long COVID. Over the last five years, the Department, through the National Institute for Health and Care Research (NIHR), has allocated £6.64 million of funding to support 10 research projects, including the £3.2 million DecodeME study, co-funded with the Medical Research Council. Over the same period, the NIHR and UK Research and Innovation have awarded over £50 million for long COVID research. The NIHR remains committed to funding high-quality research to better understand the causes and health impacts of ME/CFS and long COVID, and to identify and evaluate new treatments and interventions.<\/p> It is not usual practice for the NIHR to ring-fence funds for particular topics or conditions. The NIHR welcomes funding applications for research into any aspect of human health, including ME/CFS and long COVID. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/347", "label" : {"_value" : "Biography information for Baroness Merron"}
}
, "answeringMemberPrinted" : {"_value" : "Baroness Merron"}
, "dateOfAnswer" : {"_value" : "2024-08-06", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "HL453"}
, {"_value" : "HL454"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-08-06T15:20:56.413Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-07-29", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Chronic Fatigue Syndrome: Health Services"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask His Majesty's Government, further to the Written Statement by the Secretary of State for Health and Social Care on 12 May 2022 (HCWS23), what plans are in plans to publish the cross-Government delivery plan for myalgic encephalomyelitis/chronic fatigue syndrome.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/2542", "label" : {"_value" : "Biography information for Baroness Scott of Needham Market"}
}
, "tablingMemberPrinted" : [{"_value" : "Baroness Scott of Needham Market"}
], "uin" : "HL452"}
, {"_about" : "http://data.parliament.uk/resources/1723976", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1723976/answer", "answerText" : {"_value" : " A consultation was run in 2023 on the interim delivery plan for myalgic encephalomyelitis, also known as chronic fatigue syndrome (ME/CFS). In the World ME Day Westminster Hall debate in May 2024, the current Parliamentary Under-Secretary of State for Public Health and Prevention pushed for the publication of a response to the consultation. It is now a priority for the Department, and it is our intention to publish a response in the coming months. The consultation responses, along with continued close engagement with stakeholders, will inform the development of the Final Delivery Plan<\/em>, which we aim to publish in the winter of 2024/25.<\/p>No specific assessment has been made of the proportion of the research budget allocated for ME/CFS or long COVID. Over the last five years, the Department, through the National Institute for Health and Care Research (NIHR), has allocated £6.64 million of funding to support 10 research projects, including the £3.2 million DecodeME study, co-funded with the Medical Research Council. Over the same period, the NIHR and UK Research and Innovation have awarded over £50 million for long COVID research. The NIHR remains committed to funding high-quality research to better understand the causes and health impacts of ME/CFS and long COVID, and to identify and evaluate new treatments and interventions.<\/p> It is not usual practice for the NIHR to ring-fence funds for particular topics or conditions. The NIHR welcomes funding applications for research into any aspect of human health, including ME/CFS and long COVID. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/347", "label" : {"_value" : "Biography information for Baroness Merron"}
}
, "answeringMemberPrinted" : {"_value" : "Baroness Merron"}
, "dateOfAnswer" : {"_value" : "2024-08-06", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "HL452"}
, {"_value" : "HL454"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-08-06T15:20:56.427Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-07-29", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Chronic Fatigue Syndrome: Health Services"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask His Majesty's Government, further to the Written Statement by the Secretary of State for Health and Social Care on 12 May 2022 (HCWS23), whether the cross-Government delivery plan for myalgic encephalomyelitis (ME)/chronic fatigue syndrome will include provision for hospital treatment and full consideration of how to safely prevent malnutrition in very severe ME.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/2542", "label" : {"_value" : "Biography information for Baroness Scott of Needham Market"}
}
, "tablingMemberPrinted" : [{"_value" : "Baroness Scott of Needham Market"}
], "uin" : "HL453"}
], "itemsPerPage" : 10, "next" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=1&answeringDeptId=17&min-AnswerDate=2024-04-18", "page" : 0, "startIndex" : 1, "totalResults" : 1354, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}
|